Chung Y J, Kim K M, Choi J R, Choi S W, Rhyu M G
Department of Microbiology, College of Medicine, Catholic University of Korea, Seoul, Korea.
Int J Cancer. 1999 Sep 9;82(6):782-8. doi: 10.1002/(sici)1097-0215(19990909)82:6<782::aid-ijc2>3.0.co;2-#.
Microsatellite instability (MSI)-mutator phenotype variably targets microsatellite-like sequences in coding regions of cancer-related genes. Intratumor histological heterogeneity of gastric carcinoma with MSI was evaluated and found to be linked with the topographical distribution of MSI-associated mutations. One hundred fifty tumor sites derived from 51 gastric cancer patients were microdissected with respect to histological and topographical clonality. We found 11 gastric carcinomas with a high frequency of MSI, which were characterized by marked intratumor genetic heterogeneity arising from the progressive MSI-phenotype that was associated with frameshift mutations on multiple cancer-related genes. The 11 MSI-tumor cases manifested the MSI-phenotype in 34 of 36 tumor sites tested, but not in the remaining 2 sites. Most (88.2%, 30 of 34) MSI-positive sites and most (96.2%, 25 of 26) tumor sites harboring the frameshift mutations in transforming growth factor-beta receptor type II gene exhibited intestinal-type histology, whereas the 2 MSI-negative sites were found to be of diffuse-type histology without accompanying frameshift mutations. In 2 of 5 cases harboring E2F-4 frameshift mutations, glandular structures of intestinal-type tumor were likely to be variably differentiated in relation to the extent of the mutation, i.e., the number of mutated alleles and the size of deleted or inserted base pairs. Overall, the intratumor histological heterogeneity of gastric carcinoma with MSI was associated with the progressive frameshift mutations in transforming growth factor-beta receptor type II and E2F-4 genes.
微卫星不稳定性(MSI)-突变体表型以可变方式靶向癌症相关基因编码区中的微卫星样序列。对具有MSI的胃癌的肿瘤内组织学异质性进行了评估,发现其与MSI相关突变的地形分布有关。对来自51例胃癌患者的150个肿瘤部位进行了组织学和地形克隆性方面的显微切割。我们发现11例胃癌具有高频率的MSI,其特征是肿瘤内存在明显的遗传异质性,这是由与多个癌症相关基因的移码突变相关的渐进性MSI表型引起的。在测试的36个肿瘤部位中的34个部位,这11例MSI肿瘤病例表现出MSI表型,但其余2个部位未表现出该表型。大多数(88.2%,34个中的30个)MSI阳性部位和大多数(96.2%,26个中的25个)在II型转化生长因子-β受体基因中携带移码突变的肿瘤部位表现为肠型组织学,而2个MSI阴性部位为弥漫型组织学,未伴有移码突变。在5例携带E2F-4移码突变的病例中,有2例肠型肿瘤的腺结构可能根据突变程度而发生不同程度的分化,即突变等位基因的数量以及缺失或插入碱基对的大小。总体而言,具有MSI的胃癌的肿瘤内组织学异质性与II型转化生长因子-β受体和E2F-4基因中的渐进性移码突变有关。